AQR Capital Management
SPPI

AQR Capital Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

AQR Capital Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-161,832
Closed -$126K – 2368
2022
Q2 		$126K Buy
161,832
+127,252
+368% +$112K ﹤0.01% 2059
2022
Q1 		$45K Buy
+34,580
New +$31.8K ﹤0.01% 2185
2021
Q2 		– Sell
-11,004
Closed -$36K – 2318
2021
Q1 		$36K Sell
11,004
-12,026
-52% -$43.1K ﹤0.01% 2176
2020
Q4 		$79K Hold
23,030
– – ﹤0.01% 2161
2020
Q3 		$94K Buy
+23,030
New +$87.6K ﹤0.01% 2140
2019
Q2 		– Sell
-191,027
Closed -$2.04M – 2216
2019
Q1 		$2.04M Buy
191,027
+91,026
+91% +$975K ﹤0.01% 1310
2018
Q4 		$875K Sell
100,001
-130,179
-57% -$1.66M ﹤0.01% 1564
2018
Q3 		$3.87M Sell
230,180
-385,844
-63% -$8.35M ﹤0.01% 1111
2018
Q2 		$12.9M Sell
616,024
-172,517
-22% -$3.2M 0.01% 709
2018
Q1 		$12.7M Buy
788,541
+404,435
+105% +$8.01M 0.01% 704
2017
Q4 		$7.28M Buy
384,106
+303,177
+375% +$5.49M 0.01% 891
2017
Q3 		$1.14M Buy
+80,929
New +$732K ﹤0.01% 1622
2017
Q2 		– Sell
-25,443
Closed -$165K – 2245
2017
Q1 		$165K Buy
25,443
+195
+0.8% +$1.09K ﹤0.01% 2132
2016
Q4 		$112K Hold
25,248
– – ﹤0.01% 2205
2016
Q3 		$118K Buy
+25,248
New +$150K ﹤0.01% 2219
2016
Q1 		– Sell
-61,585
Closed -$372K – 2303
2015
Q4 		$372K Buy
61,585
+39,194
+175% +$224K ﹤0.01% 1978
2015
Q3 		$134K Sell
22,391
-39,909
-64% -$277K ﹤0.01% 2106
2015
Q2 		$426K Buy
62,300
+12,949
+26% +$82.2K ﹤0.01% 1850
2015
Q1 		$300K Buy
+49,351
New +$328K ﹤0.01% 1872

Other funds holding SPPI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management's SPPI Position: Q3 2022 in Review

AQR Capital Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2022, closing a stake of 161,832 shares — an estimated $126K sold.

AQR Capital Management first reported a position in SPPI in Q1 2015 and held it in 19 quarters. The position peaked at $12.9M in Q2 2018. 75 funds tracked by Wall St. Rank hold SPPI as of Q3 2022.

  • AQR Capital Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2022 after selling out during the quarter.
  • AQR Capital Management sold 161,832 Spectrum Pharmaceuticals Inc shares in Q3 2022, an estimated $126K.
  • AQR Capital Management first reported a position in Spectrum Pharmaceuticals Inc in Q1 2015 and held it in 19 quarters.
  • AQR Capital Management's Spectrum Pharmaceuticals Inc position peaked at $12.9M in Q2 2018.
  • 75 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2022.

Based on AQR Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.